Cancer cell therapies could be approved next year: Juno, Kite Pharma CHICAGO (Reuters) – A fresh wave of experimental cancer drugs that directly recruit the immune system`s powerful T cells could begin reaching patients next year, according to companies presenting fresh data at the annual meeting of the American Society of Clinical Oncology.